Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 2/20 | 0.34 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | GBA2 | Q9HCG7 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31146751 | 1.00 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2127384 | 1.00 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL31146650 | 1.00 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL31146641 | 1.00 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL9549761 | 1.00 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL408491 | 1.00 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL9549588 | 1.00 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL31146733 | 1.00 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL9403613 | 1.00 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL31146658 | 1.00 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 692 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4622618-B1 | PERSONAL CARE COMPOSITIONS FOR CLEANSING THE SKIN | PROCTER & GAMBLE (US) | 2026-04-22 | — | — | EP | claimed |
| US-20260096987-A1 | HYDROALCOHOLIC TOPICAL DICLOFENAC FORMULATIONS | HALEON CH SARL (CH) | 2026-04-09 | — | — | US | claimed |
| US-20260091011-A1 | HYDROALCOHOLIC SINGLE PHASE GEL COMPOSITIONS FOR TOPICAL DELIVERY OF DICLOFENAC | HALEON CH SARL (CH) | 2026-04-02 | — | — | US | claimed |
| EP-4622618-A1 | PERSONAL CARE COMPOSITIONS FOR CLEANSING THE SKIN | The Procter & Gamble Company (US) | 2025-10-01 | — | — | EP | claimed |
| US-20250235400-A1 | PROCESS OF MAKING NANOEMULSION | NICOVENTURES TRADING LTD (GB) | 2025-07-24 | — | — | US | claimed |
| EP-4051218-B1 | COSMETIC PREPARATION COMPRISING ALKALINE EARTH METAL SALTS, CARBOXYLIC ACIDS AND EMULSIFIERS HAVING BRANCHED HYDROPHOBIC CHAINS | BEIERSDORF AG (DE) | 2025-06-25 | — | — | EP | claimed |
| EP-4572733-A1 | PERSONAL CARE COMPOSITIONS FOR CLEANSING THE SKIN | The Procter & Gamble Company (US) | 2025-06-25 | — | — | EP | claimed |
| CN-120201994-A | Hydroalcoholic single phase gel compositions for topical delivery of diclofenac | 赫力昂消费者保健有限责任公司 | 2025-06-24 | — | — | CN | claimed |
| CN-120154548-A | Composition for dyeing hair comprising an ultra-high-efficiency aqueous multilayer emulsion system and process for its preparation | 酷姆国际公司 | 2025-06-17 | — | — | CN | claimed |
| CN-120154547-A | Composition for dyeing hair comprising an ultra-high-efficiency aqueous multilayer emulsion system and process for its preparation | 酷姆国际公司 | 2025-06-17 | — | — | CN | claimed |
| CN-109350578-B | Cosmetic liquid, preparation method thereof and tyrosinase inhibitor | 广州市科能化妆品科研有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-109350579-B | Whitening cosmetic additive, whitening skin-refreshing lotion and preparation method thereof | 广州市科能化妆品科研有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-114173756-A | Hydrophilized inorganic powder and cosmetic containing the same | 三好化成株式会社 | 2022-03-11 | — | — | CN | claimed |
| CN-109528589-B | Tyrosinase inhibitor, whitening repair cream and preparation method thereof | 广州市科能化妆品科研有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-109431908-B | Whitening and moisturizing cream, preparation method thereof and whitening cosmetic additive | 广州市科能化妆品科研有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-114144161-A | Oil-in-water sunscreen compositions | 拜尔斯道夫股份有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-114144164-A | Hydrophilized inorganic powder and cosmetic containing the same | 三好化成株式会社 | 2022-03-04 | — | — | CN | claimed |
| CN-114126578-A | Hydrophilized organic powder and cosmetic containing the same | 三好化成株式会社 | 2022-03-01 | — | — | CN | claimed |
| EP-3697374-B1 | AEROSOL FOAM SKIN CLEANSER | PROCTER & GAMBLE (US) | 2022-02-16 | — | — | EP | claimed |
| EP-3946642-A1 | SUNSCREEN COMPOSITIONS AND METHOD OF USE THEREOF | ISP Investments LLC (US) | 2022-02-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096987-A1 | HYDROALCOHOLIC TOPICAL DICLOFENAC FORMULATIONS | IL33, DSG1, PTGES3 | MEN1 4766/4885KMT2A 4173/4885THRB 3185/4885 |
| US-20260091011-A1 | HYDROALCOHOLIC SINGLE PHASE GEL COMPOSITIONS FOR TOPICAL DELIVERY OF DICLOFENAC | PTGER3, DGAT2, DGAT1 | MEN1 4474/4885KMT2A 4266/4885THRB 2633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.